Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

NCT01760993 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized.

Conditions

Interventions

Sponsor

Shire